SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma-Reference-Cited by-同舟云学术

SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma

Published:2023-06-28 Issue:2 Volume:26 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Ye Li-Juan¹,Xu Kai-Min²,Bai Gang³,Yuan Jing⁴,Ran Feng-Ming⁵

Affiliation:

1. Department of Pathology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan 650118, P.R. China

2. Departments of Pathology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan 650118, P.R. China

3. Department of Neurosurgery, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan 650118, P.R. China

4. Departments of Pathology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan 650118, P.R. China

5. Department of Pathology, The Third Affiliated Hospital of Kunming Medical University (Yunnan Cancer Hospital), Kunming, Yunnan 650118, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference27 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Neural stem cells and the origin of gliomas;Sanai;N Engl J Med,2005

3. The 2021 WHO Classification of tumors of the central nervous system: A summary;Louis;Neuro Oncol,2021

4. WHO CNS5 2021 classification of gliomas: A practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation;Sejda;Folia Neuropathol,2022

5. Glioma Groups Based on 1p/19q, IDH, and TERT promoter mutations in tumors;Eckel-Passow;N Engl J Med,2015